Gomez L, Jurk D
Subcell Biochem. 2024; 107:91-116.
PMID: 39693021
DOI: 10.1007/978-3-031-66768-8_5.
Han F, Riaz F, Pu J, Gao R, Yang L, Wang Y
Biomolecules. 2024; 14(10).
PMID: 39456194
PMC: 11506250.
DOI: 10.3390/biom14101261.
Palmer D, Henze L, Murua Escobar H, Walter U, Kowald A, Fuellen G
BMJ Open. 2024; 14(9):e088181.
PMID: 39349378
PMC: 11448215.
DOI: 10.1136/bmjopen-2024-088181.
Konstantinou E, Longange E, Kaya G
Biology (Basel). 2024; 13(9).
PMID: 39336075
PMC: 11428750.
DOI: 10.3390/biology13090647.
OReilly S
Clin Exp Immunol. 2023; 219(1).
PMID: 37458231
PMC: 11771193.
DOI: 10.1093/cei/uxad077.
Determining the feasibility of characterising cellular senescence in human skeletal muscle and exploring associations with muscle morphology and physical function at different ages: findings from the MASS_Lifecourse Study.
Habiballa L, Hruby A, Granic A, Dodds R, Hillman S, Jurk D
Geroscience. 2023; 46(1):1141-1158.
PMID: 37434081
PMC: 10828484.
DOI: 10.1007/s11357-023-00869-4.
Senotherapeutic Effect of Retinaldehyde and Hyaluronate Fragments in Dermatoporosis.
Kaya A, Saurat J, Kaya G
Dermatopathology (Basel). 2023; 10(2):168-172.
PMID: 37366799
PMC: 10297671.
DOI: 10.3390/dermatopathology10020024.
Repurpose dasatinib and quercetin: Targeting senescent cells ameliorates postmenopausal osteoporosis and rejuvenates bone regeneration.
Wang Y, Che L, Chen X, He Z, Song D, Yuan Y
Bioact Mater. 2023; 25:13-28.
PMID: 37056256
PMC: 10088057.
DOI: 10.1016/j.bioactmat.2023.01.009.
Cellular senescence in skin-related research: Targeted signaling pathways and naturally occurring therapeutic agents.
Danczak-Pazdrowska A, Gornowicz-Porowska J, Polanska A, Krajka-Kuzniak V, Stawny M, Gostynska A
Aging Cell. 2023; 22(6):e13845.
PMID: 37042069
PMC: 10265178.
DOI: 10.1111/acel.13845.
Dasatinib Attenuates Fibrosis in Keloids by Decreasing Senescent Cell Burden.
Darmawan C, Hur K, Kusumaningrum N, Chung J, Lee S, Mun J
Acta Derm Venereol. 2023; 103:adv4475.
PMID: 37021598
PMC: 10108619.
DOI: 10.2340/actadv.v103.4475.
Senescent Cells Accumulate in Systemic Sclerosis Skin.
Shi B, Tsou P, Ma F, Mariani M, Mattichak M, LeBrasseur N
J Invest Dermatol. 2022; 143(4):661-664.e5.
PMID: 36191640
PMC: 10038878.
DOI: 10.1016/j.jid.2022.09.652.
PLG nanoparticles target fibroblasts and MARCO+ monocytes to reverse multiorgan fibrosis.
Xu D, Bhattacharyya S, Wang W, Ifergan I, Wong M, Procissi D
JCI Insight. 2022; 7(5).
PMID: 35104243
PMC: 8983146.
DOI: 10.1172/jci.insight.151037.
Evidence of telomere attrition and a potential role for DNA damage in systemic sclerosis.
Usategui A, Municio C, Arias-Salgado E, Martin M, Fernandez-Varas B, Del Rey M
Immun Ageing. 2022; 19(1):7.
PMID: 35086525
PMC: 8793167.
DOI: 10.1186/s12979-022-00263-2.
NAD, Senolytics, or Pyruvate for Healthy Aging?.
Zhou F
Nutr Metab Insights. 2021; 14:11786388211053407.
PMID: 34720589
PMC: 8552375.
DOI: 10.1177/11786388211053407.
Therapeutic Approaches to Systemic Sclerosis: Recent Approvals and Future Candidate Therapies.
Lescoat A, Roofeh D, Kuwana M, Lafyatis R, Allanore Y, Khanna D
Clin Rev Allergy Immunol. 2021; 64(3):239-261.
PMID: 34468946
PMC: 9034469.
DOI: 10.1007/s12016-021-08891-0.
Upcoming treatments for morphea.
Wenzel D, Haddadi N, Afshari K, Richmond J, Rashighi M
Immun Inflamm Dis. 2021; 9(4):1101-1145.
PMID: 34272836
PMC: 8589364.
DOI: 10.1002/iid3.475.
New promising drugs for the treatment of systemic sclerosis: pathogenic considerations, enhanced classifications, and personalized medicine.
Lescoat A, Varga J, Matucci-Cerinic M, Khanna D
Expert Opin Investig Drugs. 2021; 30(6):635-652.
PMID: 33909517
PMC: 8292968.
DOI: 10.1080/13543784.2021.1923693.
National Institute on Aging Workshop: Repurposing Drugs or Dietary Supplements for Their Senolytic or Senomorphic Effects: Considerations for Clinical Trials.
Romashkan S, Chang H, Hadley E
J Gerontol A Biol Sci Med Sci. 2021; 76(6):1144-1152.
PMID: 33528569
PMC: 8521777.
DOI: 10.1093/gerona/glab028.
Advancements in therapeutic drugs targeting of senescence.
Zhu M, Meng P, Ling X, Zhou L
Ther Adv Chronic Dis. 2020; 11:2040622320964125.
PMID: 33133476
PMC: 7576933.
DOI: 10.1177/2040622320964125.
MicroRNAs are critical regulators of senescence and aging in mesenchymal stem cells.
Potter M, Hill W, Isales C, Hamrick M, Fulzele S
Bone. 2020; 142:115679.
PMID: 33022453
PMC: 7901145.
DOI: 10.1016/j.bone.2020.115679.
